Literature DB >> 20043091

Expression and prognostic value of Id protein family in human breast carcinoma.

Hai-Yan Yang1, Hao-Ling Liu, Jia Ke, He Wu, Hong Zhu, Jia-Ren Liu, Lian-Xin Liu, Hong-Chi Jiang.   

Abstract

Inhibitors of DNA binding/inhibitors of differentiation (Id) protein family (Id-1, -2, -3 and -4) of helix-loop-helix proteins have been shown to be involved in carcinogenesis and are regarded as prognostic markers in several types of human cancers. However, the roles of Id proteins during breast carcinoma progression remain unclear. The objective was to study the effects of Id proteins in breast cancer. The expression of Id-1, Id-2, Id-3 and Id-4 proteins was examined in 122 dissected female human breast carcinoma tissues and 22 normal female breast specimens by immunohistochemical assay and the relationship between Id staining and clinical pathological characteristics of breast cancer was also analyzed. The over-expressed Id-1 and down-regulated Id-4 proteins were found both correlated with poorer differentiation and more aggressive behavior of the tumor. Id-1 protein could be termed as a negative prognostic marker while Id-4 protein as a positive marker for patients with breast carcinoma. Although the differentially expressed Id-2 and -3 may be correlated with some clinical parameters, they could not be used as independent prognostic factors in human breast cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20043091

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  Inhibitor of DNA-binding-1/inhibitor of differentiation-1 (ID-1) is implicated in various aspects of gastric cancer cell biology.

Authors:  Wei Li; Chun-Hua Zhang; Yi-Lin Hong; Jun Li; Yong-Mei Hu; Cui-Fen Zhao
Journal:  Mol Biol Rep       Date:  2011-06-19       Impact factor: 2.316

2.  Id-1, Id-2, and Id-3 co-expression correlates with prognosis in stage I and II lung adenocarcinoma patients treated with surgery and adjuvant chemotherapy.

Authors:  Leila Antonângelo; Taila Tuma; Alexandre Fabro; Milena Acencio; Ricardo Terra; Edwin Parra; Francisco Vargas; Teresa Takagaki; Vera Capelozzi
Journal:  Exp Biol Med (Maywood)       Date:  2016-02-10

3.  ID2 and ID3 protein expression mirrors granulopoietic maturation and discriminates between acute leukemia subtypes.

Authors:  Annette M May; Anna-Verena Frey; Lioudmila Bogatyreva; Marco Benkisser-Petersen; Dieter Hauschke; Michael Lübbert; Ralph Wäsch; Martin Werner; Jens Hasskarl; Silke Lassmann
Journal:  Histochem Cell Biol       Date:  2013-11-30       Impact factor: 4.304

4.  Effects of an 11-nm DMSA-coated iron nanoparticle on the gene expression profile of two human cell lines, THP-1 and HepG2.

Authors:  Ling Zhang; Xin Wang; Jinglu Zou; Yingxun Liu; Jinke Wang
Journal:  J Nanobiotechnology       Date:  2015-01-17       Impact factor: 10.435

5.  Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.

Authors:  Xiao-Ling Zhou; Yan-Hong Ye; Shu-Ming Sun; Xiao-Feng Lu; Wei-Quan Liang; Chun-Fa Chen; Hao-Yu Lin
Journal:  Oncol Rep       Date:  2018-07-23       Impact factor: 3.906

6.  E47 and Id1 interplay in epithelial-mesenchymal transition.

Authors:  Eva Cubillo; Antonio Diaz-Lopez; Eva P Cuevas; Gema Moreno-Bueno; Hector Peinado; Amalia Montes; Vanesa Santos; Francisco Portillo; Amparo Cano
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

7.  USP1 Promotes GC Metastasis via Stabilizing ID2.

Authors:  Nuoya Li; Lei Wu; Xingye Zuo; Huilong Luo; Yanling Sheng; Jinlong Yan
Journal:  Dis Markers       Date:  2021-11-27       Impact factor: 3.434

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.